January - 2020

top of page

Sage Group News

Sage Represents Trecondi® from Medac GmbH: Novel Product for Conditioning in AML and MDS Patients:O

Sage Represents Trecondi® from Medac GmbH: Novel Product for Conditioning in AML and MDS Patients:O

Sage Represents Trecondi® from Medac GmbH: Novel Product for Conditioning in AML and MDS Patients:O

Sage Group is working with medac GmbH who have developed Trecondi®, (Treosulfan), as a superior drug in conjunction with fludarabine...

bottom of page